Rank | Gene Set | Z-score |
---|---|---|
1 | complement activation, alternative pathway (GO:0006957) | 9.98846864 |
2 | regulation of protein activation cascade (GO:2000257) | 8.58290056 |
3 | regulation of complement activation (GO:0030449) | 8.21892705 |
4 | regulation of fibrinolysis (GO:0051917) | 7.66091849 |
5 | urea metabolic process (GO:0019627) | 7.21007917 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.18759412 |
7 | L-phenylalanine catabolic process (GO:0006559) | 7.18759412 |
8 | negative regulation of fibrinolysis (GO:0051918) | 7.18508479 |
9 | glyoxylate metabolic process (GO:0046487) | 6.95379187 |
10 | * drug metabolic process (GO:0017144) | 6.87080696 |
11 | oxidative demethylation (GO:0070989) | 6.66315207 |
12 | nitrogen cycle metabolic process (GO:0071941) | 6.56169052 |
13 | L-phenylalanine metabolic process (GO:0006558) | 6.53974397 |
14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.53974397 |
15 | ethanol oxidation (GO:0006069) | 6.40161647 |
16 | cellular glucuronidation (GO:0052695) | 6.39262405 |
17 | opsonization (GO:0008228) | 6.23439114 |
18 | uronic acid metabolic process (GO:0006063) | 6.07500339 |
19 | glucuronate metabolic process (GO:0019585) | 6.07500339 |
20 | urea cycle (GO:0000050) | 6.00583398 |
21 | protein carboxylation (GO:0018214) | 5.99766758 |
22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.99766758 |
23 | bile acid biosynthetic process (GO:0006699) | 5.96376528 |
24 | aromatic amino acid family catabolic process (GO:0009074) | 5.79934833 |
25 | blood coagulation, intrinsic pathway (GO:0007597) | 5.71602574 |
26 | protein activation cascade (GO:0072376) | 5.69658867 |
27 | complement activation (GO:0006956) | 5.63676409 |
28 | bile acid metabolic process (GO:0008206) | 5.60285583 |
29 | bile acid and bile salt transport (GO:0015721) | 5.57110760 |
30 | fibrinolysis (GO:0042730) | 5.55063719 |
31 | complement activation, classical pathway (GO:0006958) | 5.48940827 |
32 | regulation of triglyceride catabolic process (GO:0010896) | 5.46868926 |
33 | imidazole-containing compound metabolic process (GO:0052803) | 5.40472463 |
34 | serine family amino acid catabolic process (GO:0009071) | 5.32850599 |
35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.26684205 |
36 | regulation of humoral immune response (GO:0002920) | 5.24780212 |
37 | cytolysis (GO:0019835) | 5.21719671 |
38 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.12653982 |
39 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.12653982 |
40 | ethanol metabolic process (GO:0006067) | 5.06787407 |
41 | phenylpropanoid metabolic process (GO:0009698) | 4.90005193 |
42 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.80973411 |
43 | acute-phase response (GO:0006953) | 4.79209141 |
44 | negative regulation of protein activation cascade (GO:2000258) | 4.75955566 |
45 | glycine metabolic process (GO:0006544) | 4.64077225 |
46 | S-adenosylmethionine metabolic process (GO:0046500) | 4.57272390 |
47 | indole-containing compound catabolic process (GO:0042436) | 4.56535208 |
48 | indolalkylamine catabolic process (GO:0046218) | 4.56535208 |
49 | tryptophan catabolic process (GO:0006569) | 4.56535208 |
50 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.52446600 |
51 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.52446600 |
52 | alkaloid metabolic process (GO:0009820) | 4.51118306 |
53 | flavonoid metabolic process (GO:0009812) | 4.48590329 |
54 | regulation of plasminogen activation (GO:0010755) | 4.47110746 |
55 | negative regulation of blood coagulation (GO:0030195) | 4.45321912 |
56 | negative regulation of hemostasis (GO:1900047) | 4.45321912 |
57 | tyrosine metabolic process (GO:0006570) | 4.39808189 |
58 | negative regulation of sterol transport (GO:0032372) | 4.39567486 |
59 | negative regulation of cholesterol transport (GO:0032375) | 4.39567486 |
60 | glutamate metabolic process (GO:0006536) | 4.33154359 |
61 | triglyceride homeostasis (GO:0070328) | 4.13193525 |
62 | acylglycerol homeostasis (GO:0055090) | 4.13193525 |
63 | hormone catabolic process (GO:0042447) | 4.07629085 |
64 | negative regulation of coagulation (GO:0050819) | 4.04561427 |
65 | negative regulation of wound healing (GO:0061045) | 3.95326263 |
66 | alpha-amino acid catabolic process (GO:1901606) | 3.93474309 |
67 | amino-acid betaine metabolic process (GO:0006577) | 3.91987370 |
68 | sodium-independent organic anion transport (GO:0043252) | 3.91435365 |
69 | arginine metabolic process (GO:0006525) | 3.89844225 |
70 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.89330295 |
71 | plasma lipoprotein particle remodeling (GO:0034369) | 3.83003741 |
72 | protein-lipid complex remodeling (GO:0034368) | 3.83003741 |
73 | macromolecular complex remodeling (GO:0034367) | 3.83003741 |
74 | tryptophan metabolic process (GO:0006568) | 3.80327977 |
75 | aromatic amino acid family metabolic process (GO:0009072) | 3.76263613 |
76 | oxaloacetate metabolic process (GO:0006107) | 3.74957270 |
77 | positive regulation of hemostasis (GO:1900048) | 3.63118190 |
78 | positive regulation of blood coagulation (GO:0030194) | 3.63118190 |
79 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.63112332 |
80 | cellular ketone body metabolic process (GO:0046950) | 3.60774707 |
81 | negative regulation of complement activation (GO:0045916) | 3.60674920 |
82 | cholesterol efflux (GO:0033344) | 3.58646241 |
83 | serine family amino acid metabolic process (GO:0009069) | 3.57418630 |
84 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.53455931 |
85 | regulation of acute inflammatory response (GO:0002673) | 3.51422872 |
86 | * xenobiotic metabolic process (GO:0006805) | 3.50062382 |
87 | intestinal cholesterol absorption (GO:0030299) | 3.44579486 |
88 | response to mercury ion (GO:0046689) | 3.42325141 |
89 | coenzyme catabolic process (GO:0009109) | 3.41295297 |
90 | acute inflammatory response (GO:0002526) | 3.38130619 |
91 | positive regulation of lipid catabolic process (GO:0050996) | 3.36348950 |
92 | high-density lipoprotein particle remodeling (GO:0034375) | 3.35071986 |
93 | positive regulation of coagulation (GO:0050820) | 3.34640745 |
94 | drug transmembrane transport (GO:0006855) | 3.34606151 |
95 | cellular amino acid catabolic process (GO:0009063) | 3.34313629 |
96 | heme transport (GO:0015886) | 3.32312225 |
97 | * exogenous drug catabolic process (GO:0042738) | 11.2111275 |
98 | * drug catabolic process (GO:0042737) | 10.2190538 |
99 | * epoxygenase P450 pathway (GO:0019373) | 10.0387693 |
100 | * omega-hydroxylase P450 pathway (GO:0097267) | 10.0035048 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.92511245 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.60057569 |
3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.76189779 |
4 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.66344952 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.50360065 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.52990526 |
7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.28963631 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.95112078 |
9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.92443786 |
10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.18720325 |
11 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.10300865 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.07093780 |
13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06431323 |
14 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.04333846 |
15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9234698 |
16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.98400957 |
17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.91578465 |
18 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.50960795 |
19 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.39905685 |
20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36659126 |
21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35458652 |
22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.25902966 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18458131 |
24 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14120818 |
25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13835915 |
26 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13220666 |
27 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.07820810 |
28 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05530645 |
29 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03655617 |
30 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02515370 |
31 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.97990531 |
32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.97242866 |
33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97203141 |
34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94823877 |
35 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94367465 |
36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92825025 |
37 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.92439340 |
38 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.90657802 |
39 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.88916143 |
40 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86088534 |
41 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.83772925 |
42 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83573229 |
43 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82999705 |
44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.82889557 |
45 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.82513356 |
46 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.82270362 |
47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82218992 |
48 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81494848 |
49 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.81453813 |
50 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.81381959 |
51 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.78897926 |
52 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.77762333 |
53 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.77710624 |
54 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.76601765 |
55 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.74583335 |
56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.74539430 |
57 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.74312386 |
58 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73957645 |
59 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.71583891 |
60 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.70747934 |
61 | AR_20517297_ChIP-Seq_VCAP_Human | 0.69891242 |
62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69610730 |
63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69610730 |
64 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68653957 |
65 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.68484956 |
66 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.66848350 |
67 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.66669742 |
68 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.66035308 |
69 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.65776145 |
70 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.65701183 |
71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.64852957 |
72 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.63663361 |
73 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.63455735 |
74 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.63455735 |
75 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.63283451 |
76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62655646 |
77 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.62220139 |
78 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61545126 |
79 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.61246549 |
80 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.60821964 |
81 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.60204135 |
82 | NFYB_21822215_ChIP-Seq_K562_Human | 0.60164598 |
83 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.60094483 |
84 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.59432753 |
85 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.58400957 |
86 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.56904858 |
87 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.55631361 |
88 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.55097403 |
89 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.53462904 |
90 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.52971426 |
91 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.52938910 |
92 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.52733256 |
93 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.52260908 |
94 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.50889014 |
95 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.50755234 |
96 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.50056280 |
97 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.49886176 |
98 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.49531527 |
99 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.49222478 |
100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.49013272 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 9.85480335 |
2 | MP0005085_abnormal_gallbladder_physiolo | 6.74567528 |
3 | MP0005360_urolithiasis | 6.07867326 |
4 | MP0005365_abnormal_bile_salt | 5.87065094 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.83767055 |
6 | MP0003252_abnormal_bile_duct | 4.89387709 |
7 | MP0002138_abnormal_hepatobiliary_system | 4.62255787 |
8 | MP0003195_calcinosis | 4.45744776 |
9 | MP0001666_abnormal_nutrient_absorption | 3.33640161 |
10 | MP0010329_abnormal_lipoprotein_level | 2.79785426 |
11 | MP0003868_abnormal_feces_composition | 2.71140542 |
12 | MP0003191_abnormal_cellular_cholesterol | 2.67123757 |
13 | MP0010368_abnormal_lymphatic_system | 2.40155033 |
14 | MP0005332_abnormal_amino_acid | 2.38971777 |
15 | MP0009697_abnormal_copulation | 1.99375021 |
16 | MP0005670_abnormal_white_adipose | 1.94624699 |
17 | MP0000609_abnormal_liver_physiology | 1.87051322 |
18 | MP0003806_abnormal_nucleotide_metabolis | 1.83910359 |
19 | MP0002118_abnormal_lipid_homeostasis | 1.67955251 |
20 | MP0009840_abnormal_foam_cell | 1.65375442 |
21 | MP0001764_abnormal_homeostasis | 1.44560370 |
22 | MP0001661_extended_life_span | 1.31830529 |
23 | MP0004019_abnormal_vitamin_homeostasis | 1.31696748 |
24 | MP0002132_abnormal_respiratory_system | 1.30389617 |
25 | MP0002876_abnormal_thyroid_physiology | 1.30168285 |
26 | MP0009053_abnormal_anal_canal | 1.14569726 |
27 | MP0005319_abnormal_enzyme/_coenzyme | 1.11844572 |
28 | MP0009764_decreased_sensitivity_to | 1.09588989 |
29 | MP0000598_abnormal_liver_morphology | 1.07019223 |
30 | MP0003656_abnormal_erythrocyte_physiolo | 1.05188014 |
31 | MP0009643_abnormal_urine_homeostasis | 1.02280805 |
32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.00551379 |
33 | MP0005408_hypopigmentation | 0.99110780 |
34 | MP0009763_increased_sensitivity_to | 0.94518596 |
35 | MP0002282_abnormal_trachea_morphology | 0.91051255 |
36 | MP0002971_abnormal_brown_adipose | 0.89669233 |
37 | MP0008872_abnormal_physiological_respon | 0.82816210 |
38 | MP0005451_abnormal_body_composition | 0.82657995 |
39 | MP0009642_abnormal_blood_homeostasis | 0.82260564 |
40 | MP0005636_abnormal_mineral_homeostasis | 0.81311553 |
41 | MP0008469_abnormal_protein_level | 0.79398383 |
42 | MP0005376_homeostasis/metabolism_phenot | 0.75393425 |
43 | MP0003690_abnormal_glial_cell | 0.74423942 |
44 | MP0001915_intracranial_hemorrhage | 0.71387674 |
45 | MP0005187_abnormal_penis_morphology | 0.71001145 |
46 | MP0005535_abnormal_body_temperature | 0.70936420 |
47 | MP0002249_abnormal_larynx_morphology | 0.68712855 |
48 | MP0005166_decreased_susceptibility_to | 0.66245135 |
49 | MP0005266_abnormal_metabolism | 0.64533878 |
50 | MP0005023_abnormal_wound_healing | 0.62975327 |
51 | MP0003879_abnormal_hair_cell | 0.62210141 |
52 | MP0005395_other_phenotype | 0.61464223 |
53 | MP0002078_abnormal_glucose_homeostasis | 0.61285165 |
54 | MP0000604_amyloidosis | 0.58969858 |
55 | MP0005334_abnormal_fat_pad | 0.56693608 |
56 | MP0002168_other_aberrant_phenotype | 0.55831800 |
57 | MP0005464_abnormal_platelet_physiology | 0.53722835 |
58 | MP0003011_delayed_dark_adaptation | 0.53188084 |
59 | MP0009765_abnormal_xenobiotic_induced | 0.50540496 |
60 | MP0004130_abnormal_muscle_cell | 0.50304201 |
61 | MP0004782_abnormal_surfactant_physiolog | 0.48616679 |
62 | MP0002332_abnormal_exercise_endurance | 0.48154035 |
63 | MP0008874_decreased_physiological_sensi | 0.46766301 |
64 | MP0003638_abnormal_response/metabolism_ | 0.44160219 |
65 | MP0005448_abnormal_energy_balance | 0.43637958 |
66 | MP0003186_abnormal_redox_activity | 0.43416059 |
67 | MP0002136_abnormal_kidney_physiology | 0.41859021 |
68 | MP0005220_abnormal_exocrine_pancreas | 0.41158240 |
69 | MP0000467_abnormal_esophagus_morphology | 0.40474311 |
70 | MP0009785_altered_susceptibility_to | 0.38590911 |
71 | MP0005666_abnormal_adipose_tissue | 0.38084514 |
72 | MP0003183_abnormal_peptide_metabolism | 0.36515037 |
73 | MP0000249_abnormal_blood_vessel | 0.35509522 |
74 | MP0009115_abnormal_fat_cell | 0.33360959 |
75 | MP0010155_abnormal_intestine_physiology | 0.32557057 |
76 | MP0000639_abnormal_adrenal_gland | 0.31922775 |
77 | MP0003075_altered_response_to | 0.31912300 |
78 | MP0003705_abnormal_hypodermis_morpholog | 0.31874320 |
79 | MP0005164_abnormal_response_to | 0.30386139 |
80 | MP0003718_maternal_effect | 0.29516205 |
81 | MP0003953_abnormal_hormone_level | 0.28935862 |
82 | MP0006036_abnormal_mitochondrial_physio | 0.27942879 |
83 | MP0005397_hematopoietic_system_phenotyp | 0.27340682 |
84 | MP0001545_abnormal_hematopoietic_system | 0.27340682 |
85 | MP0001756_abnormal_urination | 0.26706643 |
86 | MP0001881_abnormal_mammary_gland | 0.26493110 |
87 | MP0004883_abnormal_blood_vessel | 0.25103844 |
88 | MP0000566_synostosis | 0.24978729 |
89 | MP0001851_eye_inflammation | 0.24842350 |
90 | MP0001845_abnormal_inflammatory_respons | 0.24801377 |
91 | MP0005409_darkened_coat_color | 0.24429997 |
92 | MP0005083_abnormal_biliary_tract | 0.23708475 |
93 | MP0002128_abnormal_blood_circulation | 0.23424497 |
94 | MP0008775_abnormal_heart_ventricle | 0.22465877 |
95 | MP0005595_abnormal_vascular_smooth | 0.19804117 |
96 | MP0005647_abnormal_sex_gland | 0.19673261 |
97 | MP0003632_abnormal_nervous_system | 0.19572911 |
98 | MP0002928_abnormal_bile_duct | 0.18534205 |
99 | MP0002135_abnormal_kidney_morphology | 0.18308413 |
100 | MP0004272_abnormal_basement_membrane | 0.17261058 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Conjugated hyperbilirubinemia (HP:0002908) | 9.77802744 |
2 | Abnormality of complement system (HP:0005339) | 9.23958225 |
3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.14227108 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 8.58221248 |
5 | Deep venous thrombosis (HP:0002625) | 8.49828878 |
6 | Hypobetalipoproteinemia (HP:0003563) | 7.70692282 |
7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.99372933 |
8 | Intrahepatic cholestasis (HP:0001406) | 6.50441475 |
9 | Systemic lupus erythematosus (HP:0002725) | 6.21364808 |
10 | Joint hemorrhage (HP:0005261) | 5.95138625 |
11 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.58709190 |
12 | Glomerulonephritis (HP:0000099) | 5.52259231 |
13 | Hyperlipoproteinemia (HP:0010980) | 5.38339806 |
14 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.95413437 |
15 | Spontaneous abortion (HP:0005268) | 4.66553944 |
16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.53011869 |
17 | Abnormality of the intrinsic pathway (HP:0010989) | 4.41241642 |
18 | Hypolipoproteinemia (HP:0010981) | 4.40923205 |
19 | Xanthomatosis (HP:0000991) | 4.30620848 |
20 | Nephritis (HP:0000123) | 4.09022000 |
21 | Fat malabsorption (HP:0002630) | 3.95778140 |
22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.79580409 |
23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.69164157 |
24 | Hypoalphalipoproteinemia (HP:0003233) | 3.58884865 |
25 | Abnormality of methionine metabolism (HP:0010901) | 3.36357393 |
26 | Hyperammonemia (HP:0001987) | 3.20293992 |
27 | Hyperbilirubinemia (HP:0002904) | 3.03524430 |
28 | Hepatocellular carcinoma (HP:0001402) | 3.01458966 |
29 | Gingival bleeding (HP:0000225) | 2.99261993 |
30 | Hyperglycinemia (HP:0002154) | 2.94297610 |
31 | Generalized aminoaciduria (HP:0002909) | 2.84242143 |
32 | Abnormality of glycine metabolism (HP:0010895) | 2.83798650 |
33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.83798650 |
34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.83026565 |
35 | Osteomalacia (HP:0002749) | 2.77828188 |
36 | Hypercholesterolemia (HP:0003124) | 2.75735735 |
37 | Abnormality of nucleobase metabolism (HP:0010932) | 2.73741654 |
38 | Neonatal hypoglycemia (HP:0001998) | 2.73686877 |
39 | Delayed CNS myelination (HP:0002188) | 2.65609951 |
40 | Thrombophlebitis (HP:0004418) | 2.64542080 |
41 | Cholelithiasis (HP:0001081) | 2.59903565 |
42 | Epidermoid cyst (HP:0200040) | 2.57788249 |
43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.56959418 |
44 | Hyperglycinuria (HP:0003108) | 2.49884722 |
45 | Vascular calcification (HP:0004934) | 2.49322537 |
46 | Mitral stenosis (HP:0001718) | 2.46480462 |
47 | Abnormal gallbladder morphology (HP:0012437) | 2.41703190 |
48 | Elevated alkaline phosphatase (HP:0003155) | 2.39848952 |
49 | Rickets (HP:0002748) | 2.35623485 |
50 | Steatorrhea (HP:0002570) | 2.32927832 |
51 | Abnormality of serum amino acid levels (HP:0003112) | 2.31869482 |
52 | Hemorrhage of the eye (HP:0011885) | 2.30010075 |
53 | Fair hair (HP:0002286) | 2.28925213 |
54 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.23069634 |
55 | Cardiovascular calcification (HP:0011915) | 2.21582151 |
56 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.19378361 |
57 | Pulmonary embolism (HP:0002204) | 2.10905804 |
58 | Metabolic acidosis (HP:0001942) | 2.05868901 |
59 | Purpura (HP:0000979) | 2.03256487 |
60 | Joint swelling (HP:0001386) | 2.01593947 |
61 | Complement deficiency (HP:0004431) | 11.5657939 |
62 | Hyperphosphaturia (HP:0003109) | 1.99906491 |
63 | Glycosuria (HP:0003076) | 1.92485367 |
64 | Abnormality of urine glucose concentration (HP:0011016) | 1.92485367 |
65 | Ketosis (HP:0001946) | 1.90565473 |
66 | Abnormality of vitamin metabolism (HP:0100508) | 1.87357151 |
67 | Myocardial infarction (HP:0001658) | 1.87055396 |
68 | Poikilocytosis (HP:0004447) | 1.86620000 |
69 | Menorrhagia (HP:0000132) | 1.84072641 |
70 | Hydroxyprolinuria (HP:0003080) | 1.80823947 |
71 | Abnormality of proline metabolism (HP:0010907) | 1.80823947 |
72 | Hypophosphatemic rickets (HP:0004912) | 1.80659306 |
73 | Increased serum ferritin (HP:0003281) | 1.74557169 |
74 | Abnormal gallbladder physiology (HP:0012438) | 1.72907506 |
75 | Cholecystitis (HP:0001082) | 1.72907506 |
76 | Increased serum pyruvate (HP:0003542) | 1.72663156 |
77 | Abnormality of purine metabolism (HP:0004352) | 1.72142088 |
78 | Acanthocytosis (HP:0001927) | 1.71709639 |
79 | Epistaxis (HP:0000421) | 1.71374424 |
80 | Abnormality of the gallbladder (HP:0005264) | 1.68392133 |
81 | Irritability (HP:0000737) | 1.68343394 |
82 | Abnormal urine phosphate concentration (HP:0012599) | 1.67871687 |
83 | Abnormal biliary tract physiology (HP:0012439) | 1.67482020 |
84 | Bile duct proliferation (HP:0001408) | 1.67482020 |
85 | Increased mean platelet volume (HP:0011877) | 1.66150270 |
86 | Abnormality of iron homeostasis (HP:0011031) | 1.63042616 |
87 | Skin nodule (HP:0200036) | 1.59037271 |
88 | Generalized hypopigmentation of hair (HP:0011358) | 1.58627260 |
89 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.54202406 |
90 | Amyloidosis (HP:0011034) | 1.54113508 |
91 | Gout (HP:0001997) | 1.54012590 |
92 | Death in childhood (HP:0003819) | 1.51975417 |
93 | Lethargy (HP:0001254) | 1.50747594 |
94 | Enlarged kidneys (HP:0000105) | 1.50610561 |
95 | Gangrene (HP:0100758) | 1.49637287 |
96 | Abnormal platelet volume (HP:0011876) | 1.49593599 |
97 | Pancreatitis (HP:0001733) | 1.49510548 |
98 | Nephrolithiasis (HP:0000787) | 1.48836181 |
99 | Abnormality of glycolysis (HP:0004366) | 1.48603151 |
100 | Reduced antithrombin III activity (HP:0001976) | 1.48416946 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PIK3CG | 6.08456645 |
2 | ERN1 | 4.23240875 |
3 | FGFR4 | 3.68303597 |
4 | EPHA3 | 3.40420571 |
5 | RIPK1 | 2.96896218 |
6 | SIK1 | 2.44350037 |
7 | TYK2 | 2.42276207 |
8 | AKT3 | 2.31095029 |
9 | NLK | 2.26293383 |
10 | ACVR1B | 2.21815304 |
11 | PRKAA2 | 2.21611832 |
12 | PRKACG | 2.20806913 |
13 | TRIB3 | 2.19400585 |
14 | MST1R | 2.13100315 |
15 | PIK3CA | 1.97471786 |
16 | MAPK11 | 1.93350226 |
17 | FGFR3 | 1.81410978 |
18 | EPHB1 | 1.77844623 |
19 | PRPF4B | 1.74871440 |
20 | FER | 1.74773747 |
21 | BCKDK | 1.62741274 |
22 | NEK9 | 1.56378169 |
23 | JAK1 | 1.51153659 |
24 | MAP3K2 | 1.49700724 |
25 | MAP2K4 | 1.49552751 |
26 | FRK | 1.44402712 |
27 | TAOK3 | 1.42436773 |
28 | TNK2 | 1.40211025 |
29 | IGF1R | 1.36979731 |
30 | PDPK1 | 1.29849347 |
31 | MAP3K3 | 1.28385287 |
32 | CAMKK2 | 1.24343012 |
33 | KDR | 1.11843191 |
34 | MYLK | 1.11612803 |
35 | ERBB2 | 1.10472390 |
36 | RET | 1.07811598 |
37 | PDK1 | 1.02502346 |
38 | TIE1 | 0.98288974 |
39 | JAK2 | 0.94722295 |
40 | MET | 0.94356178 |
41 | PRKAA1 | 0.90425323 |
42 | ABL2 | 0.89425766 |
43 | BRSK2 | 0.88968528 |
44 | ICK | 0.88958991 |
45 | PRKCZ | 0.88099791 |
46 | NTRK3 | 0.86474479 |
47 | IRAK1 | 0.84219717 |
48 | EPHA4 | 0.83660765 |
49 | CAMK1D | 0.83352853 |
50 | SGK2 | 0.82035175 |
51 | PRKACA | 0.77854927 |
52 | MAP3K1 | 0.76252142 |
53 | SGK3 | 0.74320060 |
54 | STK39 | 0.74286841 |
55 | SCYL2 | 0.73531398 |
56 | CSF1R | 0.72726683 |
57 | PRKG1 | 0.70031909 |
58 | PRKCG | 0.68273439 |
59 | SGK223 | 0.68009766 |
60 | SGK494 | 0.68009766 |
61 | INSRR | 0.67663136 |
62 | PKN2 | 0.67430259 |
63 | MAP3K6 | 0.66539462 |
64 | CDK6 | 0.62819898 |
65 | PRKG2 | 0.58929656 |
66 | BLK | 0.58407648 |
67 | PDK2 | 0.57385434 |
68 | PRKCA | 0.54453487 |
69 | DAPK2 | 0.50570412 |
70 | WNK3 | 0.49031358 |
71 | DYRK1B | 0.48954109 |
72 | EPHA2 | 0.47541623 |
73 | PRKACB | 0.47484641 |
74 | MAPK4 | 0.47037181 |
75 | CSNK1E | 0.46683795 |
76 | PRKCB | 0.42563118 |
77 | SRC | 0.42080763 |
78 | RPS6KA3 | 0.41517441 |
79 | ERBB4 | 0.37660405 |
80 | PTK6 | 0.36644242 |
81 | MAPK7 | 0.36437968 |
82 | CAMK1G | 0.35866333 |
83 | GRK1 | 0.35853037 |
84 | CAMKK1 | 0.35117365 |
85 | TBK1 | 0.33078075 |
86 | TNIK | 0.32174493 |
87 | ZAP70 | 0.31465206 |
88 | CSNK1D | 0.30823327 |
89 | GSK3A | 0.27694247 |
90 | MAPK12 | 0.27176916 |
91 | RPS6KB1 | 0.26239186 |
92 | MTOR | 0.25016039 |
93 | CAMK2G | 0.24719556 |
94 | CSNK2A1 | 0.24510133 |
95 | KSR2 | 0.23900995 |
96 | MAPK3 | 0.22588786 |
97 | MAP3K5 | 0.22533686 |
98 | LATS1 | 0.21381729 |
99 | PRKCE | 0.21329927 |
100 | PINK1 | 0.20951197 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.43547353 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.09366097 |
3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.97089046 |
4 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.53224241 |
5 | Retinol metabolism_Homo sapiens_hsa00830 | 3.52320158 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.42389211 |
7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.26219125 |
8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.87504618 |
9 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.81030641 |
10 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.64022764 |
11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.62374565 |
12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.54088875 |
13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.47587164 |
14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.44649664 |
15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43598407 |
16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.32964315 |
17 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.31605423 |
18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.09759698 |
19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.06028588 |
20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.00201627 |
21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.98130031 |
22 | Bile secretion_Homo sapiens_hsa04976 | 1.90674638 |
23 | * Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.85948069 |
24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.85810651 |
25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85404420 |
26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.68418379 |
27 | Prion diseases_Homo sapiens_hsa05020 | 1.64058712 |
28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.59617807 |
29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.57120008 |
30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44967592 |
31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42565504 |
32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.35612430 |
33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26702823 |
34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.18974247 |
35 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.17688126 |
36 | ABC transporters_Homo sapiens_hsa02010 | 1.16166129 |
37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.12808599 |
38 | Peroxisome_Homo sapiens_hsa04146 | 1.11896970 |
39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10523234 |
40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09834741 |
41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.08829252 |
42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.03588558 |
43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96151138 |
44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94847529 |
45 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.93150995 |
46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92978075 |
47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92593849 |
48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92439696 |
49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79421600 |
50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78139263 |
51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77054368 |
52 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.75486042 |
53 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71844719 |
54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64495556 |
55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48984603 |
56 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.39443166 |
57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38923168 |
58 | Lysine degradation_Homo sapiens_hsa00310 | 0.38278429 |
59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35518988 |
60 | Pertussis_Homo sapiens_hsa05133 | 0.33388246 |
61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32139411 |
62 | Insulin resistance_Homo sapiens_hsa04931 | 0.31968285 |
63 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28219994 |
64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.27874883 |
65 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27094950 |
66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.25022307 |
67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24979319 |
68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21988668 |
69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21545484 |
70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20464307 |
71 | Mineral absorption_Homo sapiens_hsa04978 | 0.18967850 |
72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.15952113 |
73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.13207091 |
74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.12297718 |
75 | Amoebiasis_Homo sapiens_hsa05146 | 0.09457590 |
76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.09233683 |
77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09210978 |
78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.07078211 |
79 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2695107 |
80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2575413 |
81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2555463 |
82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2522227 |
83 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2455458 |
84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2357871 |
85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.2345567 |
86 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2194368 |
87 | Other glycan degradation_Homo sapiens_hsa00511 | -0.2031161 |
88 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2008756 |
89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1978080 |
90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1583151 |
91 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.1358965 |
92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1338323 |
93 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1317584 |
94 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0758085 |
95 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0653371 |
96 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.0564883 |
97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0494209 |
98 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.0445080 |
99 | * Serotonergic synapse_Homo sapiens_hsa04726 | -0.0435035 |
100 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0394623 |